These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16930665)

  • 1. Determinants of activity of the HIV-1 maturation inhibitor PA-457.
    Li F; Zoumplis D; Matallana C; Kilgore NR; Reddick M; Yunus AS; Adamson CS; Salzwedel K; Martin DE; Allaway GP; Freed EO; Wild CT
    Virology; 2006 Dec 5-20; 356(1-2):217-24. PubMed ID: 16930665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid.
    Zhou J; Chen CH; Aiken C
    Retrovirology; 2004 Jun; 1():15. PubMed ID: 15225375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
    DaFonseca S; Blommaert A; Coric P; Hong SS; Bouaziz S; Boulanger P
    Antivir Ther; 2007; 12(8):1185-203. PubMed ID: 18240859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
    Malet I; Wirden M; Derache A; Simon A; Katlama C; Calvez V; Marcelin AG
    AIDS; 2007 Apr; 21(7):871-3. PubMed ID: 17415044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS; Ablan SD; Boeras I; Goila-Gaur R; Soheilian F; Nagashima K; Li F; Salzwedel K; Sakalian M; Wild CT; Freed EO
    J Virol; 2006 Nov; 80(22):10957-71. PubMed ID: 16956950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag.
    Zhou J; Chen CH; Aiken C
    J Virol; 2006 Dec; 80(24):12095-101. PubMed ID: 17035324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E; Timilsina U; Kaplan JA; Ablan S; Ghimire D; Pham P; Kuruppu N; Mandt R; Durell SR; Nitz TJ; Martin DE; Wild CT; Gaur R; Freed EO
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants.
    Yebra G; Holguín A
    Antivir Ther; 2008; 13(8):1083-5. PubMed ID: 19195334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The R362A mutation at the C-terminus of CA inhibits packaging of human immunodeficiency virus type 1 RNA.
    Guo X; Roy BB; Hu J; Roldan A; Wainberg MA; Liang C
    Virology; 2005 Dec; 343(2):190-200. PubMed ID: 16183096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA; Luttge BG; Soheilian F; Nagashima K; Freed EO
    Virology; 2010 Apr; 400(1):137-44. PubMed ID: 20172577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S; Louis JM; Tycko R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-O-(3',3'-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro.
    Sakalian M; McMurtrey CP; Deeg FJ; Maloy CW; Li F; Wild CT; Salzwedel K
    J Virol; 2006 Jun; 80(12):5716-22. PubMed ID: 16731910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
    Gay B; Tournier J; Chazal N; Carrière C; Boulanger P
    Virology; 1998 Aug; 247(2):160-9. PubMed ID: 9705909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol.
    Chien AI; Liao WH; Yang DM; Wang CT
    Virology; 2006 Apr; 348(1):84-95. PubMed ID: 16442581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.
    Li F; Goila-Gaur R; Salzwedel K; Kilgore NR; Reddick M; Matallana C; Castillo A; Zoumplis D; Martin DE; Orenstein JM; Allaway GP; Freed EO; Wild CT
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13555-60. PubMed ID: 14573704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.
    Lin Z; Cantone J; Lu H; Nowicka-Sans B; Protack T; Yuan T; Yang H; Liu Z; Drexler D; Regueiro-Ren A; Meanwell NA; Cockett M; Krystal M; Lataillade M; Dicker IB
    PLoS Pathog; 2016 Nov; 12(11):e1005990. PubMed ID: 27893830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A; Gay B; Cransac A; Briant L; Coric P; Turcaud S; Laugâa P; Bouaziz S; Chazal N
    Antiviral Res; 2019 Apr; 164():162-175. PubMed ID: 30825471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative contribution of gag substitutions to nelfinavir-dependent enhancement of precursor cleavage and replication of human immunodeficiency virus type-1.
    Matsuoka-Aizawa S; Gatanaga H; Sato H; Koike K; Kimura S; Oka S
    Antiviral Res; 2006 Jun; 70(2):51-9. PubMed ID: 16487604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
    Adamson CS; Waki K; Ablan SD; Salzwedel K; Freed EO
    J Virol; 2009 May; 83(10):4884-94. PubMed ID: 19279107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.